% | $
Quotes you view appear here for quick access.

Amarin Corporation plc Message Board

  • lidopete lidopete Jul 19, 2012 7:37 AM Flag

    Jefferies Positive


    News Breaks
    July 19, 2012
    07:29 EDT

    Jefferies incrementally positive on AMR101 chemical entity prospects
    Jefferies says it has added confidence in Amarin's new chemical entity prospects for AMR101 after learning that the FDA originally denied the Lovaza sponsors their request to use EPA-DHA as the generic name for Lovaza. Jefferies has incrementally higher confidence in Amarin's ability to carve out EPA as a distinct active moiety and argue for five years of new chemical entity exclusivity for AMR101. The firm keeps a Buy rating on Amarin with a $26 price target.

    This topic is deleted.
2.23+0.14(+6.70%)Aug 28 4:00 PMEDT